Advertisement

Topics

Copernicus Group IRB Company Profile

23:13 EST 24th November 2017 | BioPortfolio

Copernicus Group IRB was established in July 1996 as an independent institutional review board (IRB or "Board") and operates in compliance with Federal Regulations governing institutional review boards set forth in 21 CFR, 45 CFR and ICH GCP Guidelines. Copernicus Group IRB is also a member of the Consortium of Independent Review Boards (CIRB), which regularly meets with government regulators to review issues of importance to the protection of human subjects involved in clinical research. Copernicus Group IRB has been inspected by the FDA and in July of 2004, Copernicus Group IRB was awarded full accreditation of our Human Research Protection Program by AAHRPP®, The Association for the Accreditation of Human Research Protection Programs, Inc. CGIRB is registered with OHRP as IRB00001313 which complies with all federal regulations pertaining to the protection of human research subjects

Location

118 MacKenan DriveSuite 400
Cary
North Carolina
27511
United States of America

Contact

Phone: (919) 465-4310
Fax: (919) 465-4311
Email: mafallon@cgirb.com


News Articles [268 Associated News Articles listed on BioPortfolio]

WIRB-Copernicus Group acquires eConsent tech

WIRB-Copernicus Group (WCG) has acquired eConsent technology to help clinical trial volunteers – and their families – make more informed decisions, says CEO.

WIRB-Copernicus Group partners with Veeva Systems

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, is partnering with Veeva Systems to improve the speed and accuracy of ins...

WIRB-Copernicus Group acquires FDAnews

WIRB-Copernicus Group (WCG), a provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired FDAnews, which provides global regulatory information for execu...

WIRB-Copernicus Group acquires Patient Genesis’ ConsentNow eConsent Technology

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired Patient Genesis’ ConsentNow eConsent technology. ConsentNo...

WIRB-Copernicus Group, inVentiv Health, National Institutes of Health, And More: News From July 2017

Clinical Informatics News Brief | News, products, and partnerships from around the clinical trial and healthcare community including news from WIRB-Copernicus Group, inVentiv Health, National Institut...

FDAnews Joins WIRB-Copernicus Group

  Life Sciences Jobs   ...

WIRB-Copernicus Group Acquires Patient ConsentNow eConsent Technology

  Life Sciences Jobs   ...

CISCRP Recognizes WIRB-Copernicus Group ???s Support And Donation To Clinical Trial Awareness And Education

  Life Sciences Jobs   ...

PubMed Articles [1806 Associated PubMed Articles listed on BioPortfolio]

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Protective effects of Tempol in an experimental ovarian ischemia-reperfusion injury model in female Wistar Albino rats.

The aim of this study was to investigate the antioxidant effects of tempol on ovarian ischemia-reperfusion injury in rats. Forty female Wistar albino rats were randomly divided into five groups: Group...

Effects of leptin on femoral fracture in rats.

In this study, our objective was to evaluate effects of leptin on fracture healing in rats. Seventy two male Sprague-Dawley (SD) rats were randomized into 3 groups. Standardized femoral fractures were...

Keeping up appearances: Strategic information exchange by disidentified group members.

Information exchange is a crucial process in groups, but to date, no one has systematically examined how a group member's relationship with a group can undermine this process. The current research exa...

Clinical Trials [3253 Associated Clinical Trials listed on BioPortfolio]

Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept

In patients with macular edema secondary to CRVO, Aflibercept demonstrated efficacy and safety in 2 parallel trials, interventional phase III studies, COPERNICUS study performed in United ...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Companies [1580 Associated Companies listed on BioPortfolio]

Copernicus Group IRB

Copernicus Group IRB was established in July 1996 as an independent institutional review board (IRB or "Board") and operates in compliance with Federal Regulations governing institutional review board...

Copernicus Therapeutics Incorporated

Copernicus Therapeutics, Inc. is a privately-held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Wester...

Copernicus Therapeutics, Inc.

Copernicus' Management and Board of Directors have experience in company management, pharmaceutical/biotechnology R&D, clinical development, and finance.

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Copernicus Group IRB" on BioPortfolio

We have published hundreds of Copernicus Group IRB news stories on BioPortfolio along with dozens of Copernicus Group IRB Clinical Trials and PubMed Articles about Copernicus Group IRB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Copernicus Group IRB Companies in our database. You can also find out about relevant Copernicus Group IRB Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record